Avinger (NASDAQ:AVGR) released its quarterly earnings data on Tuesday. The medical device company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.51) by ($0.05), Bloomberg Earnings reports. The firm had revenue of $2.02 million for the quarter.
Shares of NASDAQ:AVGR remained flat at $$0.32 during mid-day trading on Thursday. 310,451 shares of the stock traded hands, compared to its average volume of 967,707. The company has a market cap of $3.50 million, a price-to-earnings ratio of 0.00 and a beta of 1.99. Avinger has a 12 month low of $0.27 and a 12 month high of $11.96.
Separately, Zacks Investment Research upgraded shares of Avinger from a “sell” rating to a “hold” rating in a research note on Tuesday, October 16th.
TRADEMARK VIOLATION NOTICE: “Avinger (AVGR) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3943360/avinger-avgr-releases-quarterly-earnings-results-misses-expectations-by-0-05-eps.html.
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
See Also: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.